Review Article
[Retracted] A Comprehensive Review on Metabolic Syndrome
Table 5
Goals for lowering LDL-C [
173].
| Risk category | LDL-C goals | Recommendations |
| Lower risk 0-1 major risk factor 10-yr risk <10% | <160 mg/dL | Lifestyle modifications Consider pharmacotherapy if LDL-C ≥190 mg/dL after lifestyle modifications |
| Moderate risk ≥2 major risk factors 10-yr risk <10% | <130 mg/dL | Lifestyle modifications Consider pharmacotherapy if LDL-C ≥160 mg/dL after lifestyle modifications |
| Moderately high risk ≥2 major risk factors 10-yr risk 10–20% | <130 mg/dL Optional <100 mg/dL | Lifestyle modifications Consider pharmacotherapy if LDL-C ≥130 mg/dL or optionally ≥100 mg/dL after lifestyle modifications |
| High risk CHD or CHD risk equivalents | <100 mg/dL Optional <70 mg/dL | Lifestyle modifications Consider pharmacotherapy if LDL-C ≥100 mg/dL or optionally ≥70 mg/dL after lifestyle modifications |
|
|